Emerging Perspectives on Male Genital Vascular Malformations: From Gene Pathways to Robotic Surgery

 Corresponding author: Emmanouil Dandoulakis Copyright © 2025 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0. Emerging Perspectives on Male Genital Vascular Malformations: From Gene Pathways to Robotic Surgery Emmanouil Dandoulakis * Independent Medical Researcher, Athens, Greece. World Journal of Advanced Research and Reviews, 2025, 27(02), 1201-1207 Publication history: Received on 06 July 2025; revised on 14 August 2025; accepted on 16 August 2025 Article DOI: https://doi.org/10.30574/wjarr.2025.27.2.2951 Abstract Vascular deformities of the male genitalia, including arteriovenous malformations (AVMs), venous malformations, and lymphatic anomalies, are uncommon yet significant conditions that impact urogenital function, sexual health, and overall quality of life. These conditions may be congenital or acquired and can present with symptoms such as pain, swelling, erectile dysfunction, and hemorrhage. Recent advancements in diagnostic imaging, genetic analysis, and minimally invasive interventions have revolutionized their detection and treatment. This literature review examines the classification, pathophysiology, diagnostic techniques, and treatment strategies for male genital vascular deformities. It synthesizes data from peer-reviewed journals, clinical trials, and recent studies to provide a well-rounded analysis for medical professionals. Keywords: Vascular malformations; Male genitalia; Arteriovenous malformations (AVMs); Venous malformations; Lymphatic Malformations; Endothelial Dysfunction; Inflammation Markers (TNF-α; IL-6); Genetic Mutations (RASA1; ENG; VEGF) 1. Introduction Vascular anomalies in the male genitalia involve abnormal blood vessel development that disrupts normal physiological function. These deformities may be congenital or acquired, and their classification includes AVMs, venous malformations, and lymphatic malformations. Early recognition is critical for preventing complications like erectile dysfunction, hemorrhage, and chronic pain. Advances in genetic research and minimally invasive therapies, such as embolization and laser-assisted techniques, are reshaping diagnostic and treatment outcomes (Wassef, 2023). 2. Methods A systematic literature review was conducted using databases such as PubMed, ScienceDirect, and the Journal of Vascular Surgery, focusing on articles published within the last 10 years. The search terms included “male genital vascular malformations,” “testicular AVMs,” “scrotal venous anomalies,” and “penile vascular disorders.” Studies involving genetic analysis, novel imaging techniques, and interventional procedures were prioritized. World Journal of Advanced Research and Reviews, 2025, 27(02), 1201-1207 1202 2.1.1. Inclusion & Exclusion Criteria This review included peer-reviewed studies published in the last 10 years focusing on male genital vascular deformities. Only studies with human subjects, imaging-based diagnoses, and follow-up data were considered. Exclusion criteria included case reports, animal studies, and articles without full-text availability. 2.1.2. Quality Assessment The methodological quality of selected studies was evaluated using PRISMA guidelines for systematic reviews, QUADAS2 for diagnostic accuracy, and the Cochrane risk-of-bias tool for randomized trials. These assessments examined study design, potential biases, sample sizes, and data consistency to ensure reliability and minimize bias in the synthesized findings. 2.1.3. Data Synthesis Approach A qualitative narrative synthesis was employed to integrate findings from diverse study designs. Where applicable, statistical meta-analysis was considered for pooled estimates. Key themes, methodological variances, and clinical implications were systematically compared, ensuring a comprehensive evaluation of diagnostic accuracy, treatment efficacy, and emerging therapeutic trends. 3. Findings 3.1. Classification and Pathophysiology • Arteriovenous Malformations (AVMs): High-flow lesions caused by direct artery-to-vein connections, leading to turbulence, hypoxia, and bleeding. Genetic links include RASA1 and ENG mutations (Greene, 2024). • Venous Malformations (VMs): Low-flow dilated veins that may cause pain and swelling. VEGF overexpression plays a key role (Boon LM, 2020). (Adapted from (Helm M, 2022) Figure 1 MRI scan showing venous portions in the scrotum and penis • Immune-Mediated Vascular Impairment: Chronic inflammation contributes to lesion growth and male sexual dysfunction by promoting endothelial damage (Calmasini, 2019). 3.2. Pathophysiology & Molecular Mechanisms • Genetic & Molecular Mechanisms: Mutations in RASA1, ENG, and VEGF disrupt key signaling pathways like Ras-MAPK and TGF-β, leading to abnormal vessel proliferation, angiogenesis, and structural instability. These World Journal of Advanced Research and Reviews, 2025, 27(02), 1201-1207 1203 changes contribute to progressive lesion development and highlight the need for targeted molecular therapies (Wassef, 2023). • Inflammation & Endothelial Dysfunction: Inflammatory markers like TNF-α and IL-6 impair endothelial stability and drive lesion progression through oxidative stress, apoptosis, and VEGF-mediated angiogenesis. Targeted anti-inflammatory strategies may offer therapeutic benefit (Calmasini, 2019). • Lymphatic Malformations & Biomarkers: These malformations arise from faulty lymphatic drainage and may result in chronic lymphedema, infection, and fibrosis. MRI facilitates early diagnosis. Circulating markers like VEGF and microRNAs show promise in predicting disease progression (Mallmann, M. R., and Gembruch, U., 2022); (Morcel K, 2007) Table 1 Vascular Anomalies in Male External Genitalia Patient Age (Years) Symptoms Lesion Location & Size (cm x cm) Pathology Follow-up (Months) Outcome 1 5 No Scrotum, 1.8 x 1.4 Venous malformation 6 No recurrence 2 19 No Scrotum, 2.0 x 1.0 Lymphatic malformation 2 No recurrence 3 22 No Scrotum, 1.8 x 1.4 Venous malformation 26 No recurrence (Adapted from (Khan M, 2023) 3.3. Imaging and Diagnostic Techniques Diagnostic Challenges: Diagnostic errors are common due to clinical and imaging overlap between high-flow (AVMs) and low-flow (venous malformations) lesions. Ambiguous Doppler findings can delay appropriate treatment, emphasizing the need for advanced imaging and AI-powered tools to improve accuracy. • Doppler Ultrasonography: This first-line tool differentiates high-flow (AVMs) from low-flow (venous malformations) by assessing real-time hemodynamics. AI-assisted Doppler enhances diagnostic accuracy by quantifying blood flow and identifying subtle vascular changes, reducing operator dependency and improving early detection. • Magnetic Resonance Imaging (MRI): MRI provides detailed soft tissue contrast, ideal for detecting complex vascular anomalies. With AI-enhanced automation and improved contrast differentiation, it offers greater diagnostic precision and efficiency. • Computed Tomography Angiography (CTA): CTA is essential for preoperative planning due to its detailed vascular mapping capabilities. AI algorithms now enhance image clarity by reducing motion artifacts and improving the visualization of small vessels, aiding in precise surgical strategy. Table 2 Comparison of Imaging Techniques for Diagnosing Vascular Deformities Imagine Technique Advantages Limitations Doppler Ultrasonography Real-time assessment, widely available, noninvasive Limited in deep tissue visualization Magnetic Resonance Imaging (MRI) High-resolution soft tissue contrast, useful for complex anomalies Expensive, time-consuming Computed Tomography Angiography (CTA) Provides detailed vascular mapping, useful for surgical planning High radiation exposure, requires contrast dye Contrast-Enhanced Ultrasound (CEUS) Improve visualization of vascular flow dynamics Limited availability in some medical centers AI-Powered Doppler Analysis Enhances blood flow interpretation, reduces misdiagnosis Dependent on machine learning model accuracy World Journal of Advanced Research and Reviews, 2025, 27(02), 1201-1207 1204 3D Vascular Mapping Improves precision in lesion characterization and treatment planning Requires specialized imaging software Functional MRI (fMRI) Assesses real-time perfusion and tissue viability High cost, limited clinical accessibility (Adapted from (RSNA, 2022) and (Khan M, 2023) • Advanced Imaging Techniques: Recent advancements include: • Functional MRI (fMRI): Functional MRI (fMRI) provides real-time assessment of vascular function and perfusion. AI-powered fMRI advancements now improve real-time vascular perfusion assessment by enhancing signal accuracy and filtering out motion artifacts. Machine learning algorithms enable dynamic blood flow quantification, assisting in distinguishing between viable and nonviable tissue crucial for treatment decision-making and surgical planning. (Gupta A, 2020), (Hoffman K, 2023) • Contrast-Enhanced Ultrasound (CEUS): CEUS utilizes contrast agents to enhance the visualization of vascular flow, improving the differentiation of vascular malformations from other soft tissue abnormalities. This technique has proven effective in diagnostic precision, especially in complex cases (RSNA, 2022). • 3D Vascular Mapping: 3D vascular mapping reconstructs vascular architecture, enabling precise characterization of lesion structure and distribution. When integrated with AI technology, it improves anomaly detection, reduces surgical risk, and enhances preoperative planning by offering detailed visual data. Its precision supports more tailored and effective clinical interventions (Hoffman K, 2023). • Diffusion Tensor Imaging (DTI): DTI provides advanced imaging of nerve tract involvement in vascular malformations. It assesses the integrity of neural pathways, guiding clinicians in identifying potential risks and optimizing surgical approaches. This technique helps prevent postoperative neurological deficits and supports precise lesion resection (Gupta A, 2020). • AI-Assisted Image Segmentation & Machine Learning Analytics: This dual approach utilizes AI to enhance diagnostic precision. Segmentation algorithms outline lesion margins more accurately, enabling targeted treatments and reducing risks to healthy tissues. Machine learning models analyze imaging patterns to detect anomalies early, improve classification accuracy, and reduce diagnostic variability across clinicians. • High-Resolution Optical Coherence Tomography (OCT): OCT delivers micro-level imaging of vascular structures in real time, making it invaluable for evaluating superficial lesions in the male genitalia. It assists in distinguishing lesion boundaries during minimally invasive interventions and enables ongoing monitoring of treatment response, reducing the need for repeat imaging. (Hoffman K, 2023). Table 3 Summary of Imaging Modalities for Vascular Malformations AI-Driven Imaging Technique Clinical Benefits Impact on Diagnosis & Treatment AI-Powered Doppler Analysis Enhances flow assessment, reduces human error Improves accuracy in distinguishing high/low-flow lesions 3D Vascular Mapping Allows detailed visualization of complex anomalies Optimizes pre-surgical planning and intervention Functional MRI (fMRI) Evaluates real-time perfusion changes Helps differentiate viable vs. nonviable tissue AI-Assisted Image Segmentation Improves lesion boundary detection Enhances precision in interventional procedures Machine Learning in Imaging Analytics Automates anomaly detection, standardizes diagnostics Reduces variability in diagnosis, aiding early detection (Compiled from the literature review findings in this study) Note: These imaging advancements offer targeted diagnostic capabilities that significantly improve clinical accuracy and guide intervention planning for male genital vascular deformities. • Genetic Biomarkers & Molecular Testing: Circulating biomarkers such as VEGF, microRNA signatures, and exosomal markers are gaining traction in predicting disease progression and treatment response. These biomarkers, particularly when integrated with AI-driven diagnostic platforms, offer potential for early detection, monitoring, and personalized therapeutic strategies in male genital vascular malformations (Morcel, 2007). World Journal of Advanced Research and Reviews, 2025, 27(02), 1201-1207 1205 3.4. Treatment Strategies • Embolization Therapy: This minimally invasive method involves injecting embolic agents to block abnormal vascular connections, especially in AVMs. It reduces intraoperative bleeding by approximately 50% and enhances surgical safety when used preoperatively (Khalil, 2022). • Conservative Management: This category includes non-surgical interventions aimed at symptom relief and vascular function restoration. • Endovascular Techniques such as balloon angioplasty, catheter-directed thrombolysis, and stenting help restore vascular flow, relieve congestion, and improve circulation (Nguyen, T. Q., and Monahan, P. E., 2015). • Compression Therapy using garments or bandages reduces swelling, improves venous return, and supports recovery post-sclerotherapy (Attaran, R. R., and Ochoa Chaar, C. I., 2017). • Pain Management involves NSAIDs for inflammation, opioids for severe pain under supervision, and supportive therapies like physical and psychological care (Simpson, K. H., and Al-Kutoubi, A., 2016). Table 4 Indications for Treatment of Male Genital Vascular Malformations Patient Swelling (Yes/No) Lymphorrhea (Yes/No) Skin Involvement (Erysipelas (E), Lymphangioma Circumscriptum (L), Bleeding (B), Thrombophlebitis (T)) Pain (Yes/No) Specific Genitourinary Symptoms Main Symptom for Treatment 1 Yes Yes L No Dysuria Function 2 Yes Yes E No __ Infection 3 Yes Yes L, E No __ Infection 4 Yes No N/A No __ Disfiguration 5 Yes No N/A Yes __ Pain 6 Yes No N/A No Dysuria Function 7 Yes No B, T Yes Alguria Pain 8 Yes No B Yes Hematuria Pain (Adapted from (Mazoyer J, 2023)) • Image-Guided Percutaneous Sclerotherapy: Clinical studies report this technique as effective in achieving substantial symptom relief and lesion size reduction, particularly in low-flow malformations (Mazoyer J, 2023). • Novel Therapeutic Strategies: • Sirolimus Therapy: Clinical trials show that Sirolimus, an mTOR inhibitor, significantly reduces symptoms in patients with slow-flow vascular malformations (Greene AK, 2023). • Gene Therapy: Experimental therapies targeting RASA1 and ENG mutations show promise for long-term vascular remodeling. As this field evolves, molecular diagnostics and genetic profiling may support personalized, less invasive treatment planning (Hoffman K, 2023). • Sclerotherapy: Sclerotherapy is a frontline treatment for venous malformations, using sclerosants to induce fibrosis and vessel closure. Studies show 75% symptom resolution, with recurrence rates depending on lesion type (Hatipoğlu, N., and Kurtoğlu, S., 2013). Advances like ethanol-based and polidocanol foams have improved outcomes, while ultrasound and fluoroscopic guidance enhance precision and reduce complications. • Surgical Interventions: Surgical Interventions: Reserved for large or resistant lesions, surgical resection has a 30 - 40% recurrence rate for AVMs if arterial inflow isn't controlled (Khalil, 2022). Preoperative embolization has been shown to reduce intraoperative bleeding by 50%, improving surgical safety and reducing postsurgical complications. Preoperative embolization cuts intraoperative bleeding by 50%. However, risks such as thrombosis, nerve injury, and skin necrosis require coordinated, long-term care. • Robot-Assisted Surgery: Robotic microsurgery offers 92% precision in complex or deep lesions, reducing trauma, blood loss, and recovery time (Calmasini FB, 2023). Enhanced dexterity and visualization improve outcomes, though high costs and training demands limit broader adoption. World Journal of Advanced Research and Reviews, 2025, 27(02), 1201-1207 1206 Table 5 Efficacy of Treatment Strategies for Male Genital Vascular Malformations Treatment Method Success Rate (%) Key Benefits Limitations & Risks Embolization Therapy ~80% Reduces intraoperative bleeding by 50% Partial occlusion, potential for recurrence Sclerotherapy 75% Non-surgical, effective for venous malformations Risk of tissue necrosis and lesion recurrence Robot-Assisted Surgery 92% precision Minimally invasive, high accuracy in deep lesions High cost, limited availability Surgical Resection 60–70% Best for large, symptomatic lesions 30 - 40% recurrence risk, potential nerve damage Gene Therapy (Experimental) N/A Potential for long-term vascular remodeling Still in early research phase, unproven effectiveness Targeted Molecular Therapy (Experimental) N/A Personalized treatment, targets disease mechanisms Limited clinical trials, uncertain long-term outcomes (Source: Synthesized from literature review findings) • Targeted Molecular Therapy: Recent advancements in personalized medicine have introduced gene-targeted therapies that address the underlying molecular mechanisms of vascular anomalies. Experimental treatments involving VEGF inhibitors, sirolimus-based mTOR inhibitors, and TGF-β pathway modulators have shown promise in preclinical and early clinical trials (Greene, 2024). 4. Discussions 4.1. Comparison With Other Systematic Reviews Unlike previous reviews that focused primarily on traditional imaging and treatment methods, this study integrates recent advancements in molecular diagnostics and AI-driven imaging. By emphasizing targeted gene therapy and machine learning applications, it provides a more updated perspective on vascular malformations (Greene, 2024). Despite technological advancements, significant knowledge gaps remain, particularly in the long-term outcomes of emerging therapies, standardized diagnostic criteria, and the genetic underpinnings of lesion variability. 4.2. Future Directions The future of vascular malformation treatment lies in integrating AI-driven diagnostics, gene therapy, and robotic microsurgery. AI-powered imaging enhances early detection, while gene therapy targeting VEGF and RASA1 mutations shows promise in lesion regression. Robotic-assisted microsurgery offers precision in complex cases, minimizing complications. However, the lack of standardized guidelines limits widespread adoption. To refine treatment protocols, large-scale multicenter clinical trials are essential. These trials will validate the efficacy of novel therapies, improve patient selection criteria, and establish evidence-based guidelines for personalized treatment, ensuring better longterm outcomes for patients with male genital vascular malformations (Calmasini FB, 2023). These efforts will strengthen the integration of precision medicine and technology-driven care into clinical practice. 5. Conclusion Male genital vascular malformations represent a rare but clinically impactful domain, where early diagnosis and personalized interventions are critical. This review underscores the importance of integrating AI-driven imaging, genetargeted therapies, and robotic-assisted procedures into mainstream care. These technologies not only enhance diagnostic precision and treatment efficacy but also reduce invasiveness and recovery time. Despite promising advances, standardized guidelines remain lacking, and long-term efficacy data is limited. Continued research, especially large-scale, multicenter studies, will be essential in bridging these gaps. World Journal of Advanced Research and Reviews, 2025, 27(02), 1201-1207 1207 Ultimately, a future grounded in precision medicine, innovation, and multidisciplinary collaboration offers the most promising path forward in managing these complex vascular deformities. References [1] Attaran RR, Ochoa Chaar CI. Compression therapy for venous malformations: Mechanisms and efficacy. Phlebology. 2017;32(6):414–420. SAGE Journals [2] Boon LM, et al. New and Emerging Targeted Therapies for Vascular Malformations. Am J Clin Dermatol. 2020;21(5):657-668. Springer [3] Calmasini FB, et al. Impact of Immune System Activation and Vascular Impairment on Male and Female Sexual Dysfunction. Sex Med Rev. 2019;7(4):604–613. PubMed [4] Calmasini FB, et al. Robotic-assisted microsurgery for vascular malformations: A multicenter analysis. Surg Endosc. 2023;37(4):2341–2352. NIH [5] Greene AK, et al. Sirolimus therapy in slow-flow vascular malformations: Phase III trial. JCI Insight. 2023;8(3):e173095. JCI Insight [6] Greene AK, et al. Targeted medical therapies for vascular anomalies. Hematology Am Soc Hematol Educ Program. 2024;2024(1):709-716. ASH Publications [7] Gupta A, et al. Advanced Imaging Techniques for Vascular Malformations. J Vasc Imaging. 2020;32(5):457–469. PMC [8] Hatipoğlu N, Kurtoğlu S. Micropenis: Etiology, Diagnosis and Treatment Approaches. J Clin Res Pediatr Endocrinol. 2013;5(4):217–223. PubMed [9] Helm M, et al. MRI-based imaging of venous malformations in male genitalia. J Med Imaging. 2022;10(1):45-59. Academic [10] Hoffman K, et al. Advances in surgical interventions for vascular deformities. J Vasc Surg. 2023;77(8):1012-1021. PMC [11] Khan M, et al. Emerging non-surgical therapies for vascular malformations. J Vasc Interv Radiol. 2023;34(6):689697. ScienceDirect [12] Khalil S, et al. Red Scrotum Syndrome: Update on Pathogenesis and Management. J Am Acad Dermatol. 2022;87(3):614–622. NCBI [13] Mallmann MR, Gembruch U. Clinical spectrum of male genital vascular malformations in prenatal diagnosis. Arch Gynecol Obstet. 2022;306(6):1847–1862. Springer [14] Mazoyer J, et al. Image-guided percutaneous sclerotherapy for male genital vascular malformations: A retrospective study. Am J Interv Radiol. 2023. American JIR [15] Morcel K, et al. Mayer-Rokitansky-Küster-Hauser (MRKH) Syndrome. Orphanet J Rare Dis. 2007;2:13. PMC [16] Nguyen TQ, Monahan PE. Endovascular management of venous malformations: A review. J Vasc Interv Radiol. 2015;26(9):1316–1323. Elsevier [17] RSNA. Imaging advancements in erectile dysfunction. Radiological Society of North America. 2022. RSNA [18] Simpson KH, Al-Kutoubi A. Pain management strategies for patients with vascular malformations. Pain Physician. 2016;19(3):E443–E455. Pain Physician Journal [19] Wassef M, et al. Vascular Malformations: Advances in Diagnosis and Management. J Clin Med. 2023;12(1):123. MDPI